DK1756571T3 - Fremgangsmåde i realtid til detektering af akut inflammatoriske tilstande - Google Patents

Fremgangsmåde i realtid til detektering af akut inflammatoriske tilstande

Info

Publication number
DK1756571T3
DK1756571T3 DK05776689.1T DK05776689T DK1756571T3 DK 1756571 T3 DK1756571 T3 DK 1756571T3 DK 05776689 T DK05776689 T DK 05776689T DK 1756571 T3 DK1756571 T3 DK 1756571T3
Authority
DK
Denmark
Prior art keywords
real
inflammatory conditions
acute inflammatory
time method
detecting acute
Prior art date
Application number
DK05776689.1T
Other languages
English (en)
Inventor
Joseph M Ahearn
Susan M Manzi
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Application granted granted Critical
Publication of DK1756571T3 publication Critical patent/DK1756571T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Washing And Drying Of Tableware (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK05776689.1T 2004-04-09 2005-04-08 Fremgangsmåde i realtid til detektering af akut inflammatoriske tilstande DK1756571T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56098604P 2004-04-09 2004-04-09
US57962104P 2004-06-14 2004-06-14
PCT/US2005/011914 WO2005108988A2 (en) 2004-04-09 2005-04-08 Real time method of detecting acute inflammatory conditions

Publications (1)

Publication Number Publication Date
DK1756571T3 true DK1756571T3 (da) 2010-12-13

Family

ID=35320843

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05776689.1T DK1756571T3 (da) 2004-04-09 2005-04-08 Fremgangsmåde i realtid til detektering af akut inflammatoriske tilstande

Country Status (9)

Country Link
US (1) US7361517B2 (da)
EP (2) EP2216650A1 (da)
JP (1) JP2007532885A (da)
AT (1) ATE478335T1 (da)
AU (1) AU2005241415A1 (da)
CA (1) CA2561684A1 (da)
DE (1) DE602005023009D1 (da)
DK (1) DK1756571T3 (da)
WO (1) WO2005108988A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004093647A2 (en) * 2003-04-16 2004-11-04 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Identification and monitoring of systematic lupus erythematosus
EP2214014A1 (en) * 2004-05-11 2010-08-04 The University of Pittsburgh Monitoring immunologic, hematologic and inflammatory diseases
EP1797197A1 (en) * 2004-09-29 2007-06-20 Mellitus S.L. Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease
AU2009305575A1 (en) * 2008-10-16 2010-04-22 Cypress Bioscience, Inc. Method for diagnosis and monitoring of disease activity and response to treatment in systemic lupus erythematosus (SLE) and other autoimmune diseases
CA2742792A1 (en) * 2008-11-24 2010-05-27 University Of Pittsburgh Of The Commonwealth System Of Higher Education Prediction and prevention of preeclampsia
WO2012075023A2 (en) * 2010-11-29 2012-06-07 Novelmed Therapeutics, Inc. Neoantibodies for diagnosing tissue injury
WO2012109592A1 (en) 2011-02-11 2012-08-16 Exagen Diagnostics, Inc. Methods for diagnosing systemic lupus erythematosus
CA2877441A1 (en) 2012-07-02 2014-01-09 Medizinische Universitat Wien Complement split product c4d for the treatment of inflammatory conditions
CN111965358A (zh) * 2013-02-08 2020-11-20 阿勒格尼-辛格研究所 细胞结合的补体激活产物作为狼疮前期诊断性生物标志物
US20160003838A1 (en) * 2013-03-14 2016-01-07 Immucor Gti Diagnostics, Inc. Methods and compositions for diagnosing preeclampsia
EP2972365B1 (en) 2013-03-15 2019-11-20 Exagen Diagnostics, Inc. Methods for treating and diagnosing systemic lupus erythematosus
JP2017528734A (ja) * 2014-08-08 2017-09-28 アレゲーニー・シンガー リサーチ インスティチュート 診断用バイオマーカーとしての抗リンパ球自己抗体

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
JPS63172963A (ja) * 1986-11-14 1988-07-16 ロバート　エイ．レビン 生物学的粒子の検出方法
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
ATE144793T1 (de) 1989-06-29 1996-11-15 Medarex Inc Bispezifische reagenzien für die aids-therapie
AU8295491A (en) 1990-06-29 1992-01-23 Biosource Technologies Incorporated Melanin production by transformed microorganisms
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
DK0814159T3 (da) 1990-08-29 2005-10-24 Genpharm Int Transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
EP0666987A4 (en) 1992-10-30 1997-08-27 T Cell Diagnostics Inc EVALUATION OF THE TOTAL QUANTITY OF A MOLECULE IN A SAMPLE AND METHODS BASED ON SAME.
WO2001064214A2 (en) * 2000-02-28 2001-09-07 The University Of British Columbia Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
DE60237529D1 (de) 2001-09-10 2010-10-14 Univ Pittsburgh Diagnose und aufzeichnung von systemischem lupus erythematosus und von skleroderm
US20030158083A1 (en) * 2002-02-08 2003-08-21 The Procter & Gamble Company Method of effecting angiogenesis by modulating the function of a novel endothelia phosphatase
ATE465275T1 (de) 2003-06-13 2010-05-15 Univ Pittsburgh Überwachung von immunologischen, hämatologischen und entzündlichen erkrankungen

Also Published As

Publication number Publication date
DE602005023009D1 (de) 2010-09-30
AU2005241415A1 (en) 2005-11-17
EP1756571B1 (en) 2010-08-18
EP1756571A4 (en) 2008-05-07
JP2007532885A (ja) 2007-11-15
US7361517B2 (en) 2008-04-22
WO2005108988A2 (en) 2005-11-17
CA2561684A1 (en) 2005-11-17
WO2005108988A3 (en) 2006-05-18
ATE478335T1 (de) 2010-09-15
EP1756571B8 (en) 2010-10-13
EP1756571A2 (en) 2007-02-28
EP2216650A1 (en) 2010-08-11
US20050282234A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
DK1756571T3 (da) Fremgangsmåde i realtid til detektering af akut inflammatoriske tilstande
EP1745287A4 (en) DIAGNOSIS AND MONITORING OF INFLAMMATORY DISEASES BY MEASURING THE ADDITIONAL COMPONENTS OF LEUKOCYTES
ATE456055T1 (de) Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden
WO2005103281A3 (en) Platelet biomarkers for the detection of disease
WO2009059150A3 (en) Biomarkers for fatty liver disease and methods using the same
BR112018070971A2 (pt) métodos e kits para a diagnose e estratificação de risco de pacientes com isquemia
ES2572372T3 (es) Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1
WO2012018535A3 (en) Wellness panel
MX2009007368A (es) Deteccion, tratamiento y monitoreo de la inflamacion, por medio del receptor de disparo expresado en la celula 1 mieloide (trem-1).
IL172488A0 (en) Diagnostic methods for monitoring immunologic, hematologic and inflammatory diseases
WO2006059252A3 (en) Methods and fluorinated compositions for treating amyloid-related diseases
NO20071831L (no) Anvendelse av unormal hendelsesdeteksjonsteknologi for hydrocrackingenheter
ATE447886T1 (de) Gerät zur überwachung der zerebralen perfusion
WO2006133287A3 (en) Expression profiles of peripheral blood mononuclear cells for inflammatory bowel diseases
WO2009101059A3 (en) Methods of using cadherin 11 (cdh11) antagonists
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
ATE524565T1 (de) Transkriptionsuntreue, nachweis und verwendungen davon
ATE550658T1 (de) Verfahren für den nachweis oder die diagnose neurodegenerativer erkrankungen oder leiden
CA2575405A1 (en) Method for diagnosing liver fibrosis
WO2007050588A3 (en) Systems and methods for characterizing conditions of organs for transplantation
WO2007084397A3 (en) Processing of slpi by chymase
WO2008117027A3 (en) Altered mitochondrial activity in diseases resulting from oxidative stress
WO2007060647A3 (en) A method for detecting or monitoring sepsis by analysing cytokine mrna expression levels
WO2006116688A3 (en) Mif agonists and antagonists and therapeutic uses thereof
DK2196545T3 (da) Fremgangsmåder til forudsigelse af reaktionen hos patienter med dissemineret sclerose på interferonbehandling samt diagnosticering af dissemineret sclerose